Ptc Therapeutics (PTCT) Return on Invested Capital Growth (5y) (2023 - 2026)

Ptc Therapeutics (PTCT) Return on Invested Capital Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Ptc Therapeutics 6.27 Bn 4.38 Bn 244.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.00
Dec 31, 2025 18.00
Sep 30, 2025 17.00
Jun 30, 2025 16.00
Mar 31, 2025 14.00
Dec 31, 2024 1.00
Sep 30, 2024 1.00
Jun 30, 2024 2.00
Mar 31, 2024 1.00
Dec 31, 2023 4.00
Sep 30, 2023 9.00